Skip to content

Amcinonide

Published: July 26, 2026Updated: August 24, 2026

Amcinonide is a topical corticosteroid medication used to treat inflammatory and itchy skin conditions such as eczema, dermatitis, and psoriasis. It is typically prescribed when milder corticosteroids have not been effective enough.

Quick summary

Amcinonide is a potent topical steroid that reduces inflammation and itching of the skin.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 24, 2026Editorial policy

Key facts at a glance

ATC
D07AC11
RxNorm
17652
Generic
Amcinonide
Class
atc-d07
Brands
—
Availability
rx
Lactation
unknown
Routes
topical
Forms
cream, ointment
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
500mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
250mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
400mg daily
Maximum
consult physician
Frequency
once daily
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Single dose that may cause serious toxicity - applicable to extensive topical application on compromised skin or occluded areas
Chronic overdose: Prolonged use over large body surface areas or with occlusive dressings can lead to systemic corticosteroid accumulation and adrenal suppression
Immediate actions
Discontinue topical application, wash affected area with soap and water, monitor for systemic symptoms
Antidote
No specific antidote exists(Supportive care and gradual discontinuation of corticosteroid therapy)
Poison Control: 1-800-222-1222

Special Populations

9 groups
⚠

pregnancy

first trimester
caution
FDA Category
C
Dose Adjustment

use lowest effective dose for shortest duration

Key Recommendations

avoid use on large surface areas or under occlusive dressings during pregnancy unless benefits outweigh risks

Monitor

regular prenatal checkups

Use with caution and monitor for adverse effects.

⚠

pregnancy

second trimester
caution
FDA Category
C
Dose Adjustment

use lowest effective dose for shortest duration

Key Recommendations

avoid application to large body surface areas

Monitor

routine prenatal monitoring

Use with caution and monitor for adverse effects.

⚠

pregnancy

third trimester
caution
FDA Category
C
Dose Adjustment

minimize use and duration

Key Recommendations

avoid extensive use particularly near term

Monitor

fetal monitoring in late pregnancy

Use with caution and monitor for adverse effects.

⚠

lactation

breastfeeding
caution
FDA Category
C
Dose Adjustment

use minimal amount and short duration

Key Recommendations

do not apply to breasts or nipple area; if needed on other areas, wash thoroughly before breastfeeding

Monitor

monitor infant for signs of adrenal suppression if extensive use

Use with caution and monitor for adverse effects.

⚠

pediatric_age

infants
caution
FDA Category
C
Dose Adjustment

use with extreme caution, reduced potency and duration

Key Recommendations

not recommended for infants due to higher skin permeability and risk of systemic absorption; avoid on diaper area under occlusive dressings

Monitor

monitor for signs of HPA axis suppression

Use with caution and monitor for adverse effects.

⚠

pediatric_age

children
caution
FDA Category
C
Dose Adjustment

use lower potency preparations when possible and limit treatment duration

Key Recommendations

avoid use on large areas, prolonged use, or under occlusive dressings in children

Monitor

monitor growth and development with long-term use

Use with caution and monitor for adverse effects.

⚠

geriatric

elderly
caution
FDA Category
C
Dose Adjustment

use with caution, start with lower frequency

Key Recommendations

skin may be thinner in elderly; avoid prolonged use on large areas; monitor for skin atrophy

Monitor

periodic skin examination for atrophy or telangiectasia

Use with caution and monitor for adverse effects.

✓

renal_impairment

mild to moderate
safe
FDA Category
C
Dose Adjustment

no adjustment typically required

Key Recommendations

standard topical use considered safe due to minimal systemic absorption

Monitor

no specific monitoring needed

✓

hepatic_impairment

mild to moderate
safe
FDA Category
C
Dose Adjustment

no adjustment typically required

Key Recommendations

standard topical use considered safe due to minimal systemic absorption

Monitor

no specific monitoring needed

Statistics and clinical data

prescribingFDA
2023

First approved

Value:1980s

Initial FDA approval year for topical formulation

drug_classWHO
2023

Drug class

Value:Topical corticosteroid

Pharmacological classification based on ATC system

potencyFDA
2023

Potency classification

Value:Super-potent (Group I)

Relative potency ranking among topical corticosteroids

usageMedical guidelines
2023

Common indications

Value:Psoriasis, eczema, dermatitis

FDA-approved therapeutic uses

Treats various inflammatory and pruritic dermatological conditions including atopic dermatitis, contact dermatitis, eczema, psoriasis, and other corticosteroid-responsive skin disorders.

As a topical corticosteroid, amcinonide works by suppressing the immune response and reducing inflammation in the skin. It decreases the production of inflammatory mediators and inhibits the migration of inflammatory cells to the affected area.

Amcinonide is a potent topical steroid and should not be used on the face, groin, or underarms unless specifically directed by a healthcare provider. It should not be used on broken or infected skin, and treatment should be limited to short durations to minimize side effects such as skin thinning. Patients should avoid covering treated areas with occlusive dressings unless instructed. Use during pregnancy or breastfeeding should be discussed with a healthcare provider.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 24, 2026. · Read our editorial policy